Page 83 - Read Online

49. Fukayama M. Epstein-Barr virus and gastric carcinoma. 65. Arnold CN, Goel A, Compton C, Marcus V, Niedzwiecki D,
Pathol Int 2010;60:337-50. Dowell JM, Wasserman L, Inoue T, Mayer RJ, Bertagnolli MM,
50. Fukayama M, Ushiku T. Epstein-Barr virus-associated gastric Boland CR. Evaluation of microsatellite instability, hMLH1
carcinoma. Pathol Res Pract 2011;207:529-37. expression and hMLH1 promoter hypermethylation in defi ning
51. Uozaki H, Fukayama M. Epstein-Barr virus and gastric the MSI phenotype of colorectal cancer. Cancer Biol Ther
carcinoma-viral carcinogenesis through epigenetic 2004;3:73-8.
mechanisms. Int J Clin Exp Pathol 2008;1:198-216. 66. Boland CR, Goel A. Microsatellite instability in colorectal
52. Ushiku T, Chong JM, Uozaki H, Hino R, Chang MS, Sudo M, cancer. Gastroenterology 2010;138:2073-87e3.
Rani BR, Sakuma K, Nagai H, Fukayama M. p73 gene 67. Bouzourene H, Hutter P, Losi L, Martin P, Benhattar J.
promoter methylation in Epstein-Barr virus-associated gastric Selection of patients with germline MLH1 mutated Lynch
carcinoma. Int J Cancer 2007;120:60-6. syndrome by determination of MLH1 methylation and BRAF
53. Hino R, Uozaki H, Murakami N, Ushiku T, Shinozaki A, mutation. Fam Cancer 2010;9:167-72.
Ishikawa S, Morikawa T, Nakaya T, Sakatani T, Takada K, 68. Baylin SB, Herman JG. DNA hypermethylation in
Fukayama M. Activation of DNA methyltransferase 1 tumorigenesis: epigenetics joins genetics. Trends Genet
by EBV latent membrane protein 2A leads to promoter 2000;16:168-74.
hypermethylation of PTEN gene in gastric carcinoma. Cancer 69. Rashid A, Shen L, Morris JS, Issa JP, Hamilton SR. CpG
Res 2009;69:2766-74. island methylation in colorectal adenomas. Am J Pathol
54. Jang BG, Kim WH. Molecular pathology of gastric carcinoma. 2001;159:1129-35.
Pathobiology 2011;78:302-10. 70. Coppede F. Epigenetic biomarkers of colorectal cancer: focus
55. Shigaki H, Baba Y, Watanabe M, Murata A, Iwagami S, on DNA methylation. Cancer Lett 2014;342:238-47.
Miyake K, Ishimoto T, Iwatsuki M, Baba H. LINE-1 71. Lao VV, Grady WM. Epigenetics and colorectal cancer.
hypomethylation in gastric cancer, detected by bisulfi te Nat Rev Gastroenterol Hepatol 2011;8:686-700.
pyrosequencing, is associated with poor prognosis. Gastric 72. Wang L, Cunningham JM, Winters JL, Guenther JC,
Cancer 2013;16:480-7. French AJ, Boardman LA, Burgart LJ, McDonnell SK,
56. Kosumi K, Baba Y, Ishimoto T, Harada K, Miyake K, Schaid DJ, Thibodeau SN. BRAF mutations in colon cancer
Izumi D, Tokunaga R, Murata A, Eto K, Sugihara H, are not likely attributable to defective DNA mismatch repair.
Shigaki H, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Cancer Res 2003;63:5209-12.
Watanabe M, Komohara Y, Takeya M, Baba H. Relationship 73. Grady WM, Rajput A, Lutterbaugh JD, Markowitz SD.
between LINE-1 hypomethylation and Helicobacter pylori Detection of aberrantly methylated hMLH1 promoter DNA in
infection in gastric mucosae. Med Oncol 2015;32:117. the serum of patients with microsatellite unstable colon cancer.
57. Hur K, Han TS, Jung EJ, Yu J, Lee HJ, Kim WH, Goel A, Cancer Res 2001;61:900-2.
Yang HK. Up-regulated expression of sulfatases (SULF1 and 74. Lofton-Day C, Model F, Devos T, Tetzner R, Distler J,
SULF2) as prognostic and metastasis predictive markers in Schuster M, Song X, Lesche R, Liebenberg V, Ebert M,
human gastric cancer. J Pathol 2012;228:88-98. Molnar B, Grutzmann R, Pilarsky C, Sledziewski A. DNA
58. Worthley DL, Leggett BA. Colorectal cancer: molecular methylation biomarkers for blood-based colorectal cancer
features and clinical opportunities. Clin Biochem Rev screening. Clin Chem 2008;54:414-23.
2010;31:31-8. 75. deVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J,
59. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Steiger KV, Grutzmann R, Pilarsky C, Habermann JK,
Issa JP. CpG island methylator phenotype in colorectal cancer. Fleshner PR, Oubre BM, Day R, Sledziewski AZ,
Proc Natl Acad Sci U S A 1999;96:8681-6. Lofton-Day C. Circulating methylated SEPT9 DNA in
60. Shen L, Toyota M, Kondo Y, Lin E, Zhang L, Guo Y, plasma is a biomarker for colorectal cancer. Clin Chem
Hernandez NS, Chen X, Ahmed S, Konishi K, Hamilton SR, 2009;55:1337-46.
Issa JP. Integrated genetic and epigenetic analysis identifi es 76. Grutzmann R, Molnar B, Pilarsky C, Habermann JK,
three different subclasses of colon cancer. Proc Natl Acad Sci Schlag PM, Saeger HD, Miehlke S, Stolz T, Model F,
U S A 2007;104:18654-9. Roblick UJ, Bruch HP, Koch R, Liebenberg V, Devos T,
61. Ide T, Kitajima Y, Ohtaka K, Mitsuno M, Nakafusa Y, Song X, Day RH, Sledziewski AZ, Lofton-Day C. Sensitive
Miyazaki K. Expression of the hMLH1 gene is a possible detection of colorectal cancer in peripheral blood by septin 9
predictor for the clinical response to 5-fl uorouracil after DNA methylation assay. PLoS One 2008;3:e3759.
a surgical resection in colorectal cancer. Oncol Rep 77. Tanzer M, Balluff B, Distler J, Hale K, Leodolter A,
2008;19:1571-6. Rocken C, Molnar B, Schmid R, Lofton-Day C, Schuster T,
62. Goel A, Arnold CN, Niedzwiecki D, Chang DK, Ebert MP. Performance of epigenetic markers SEPT9 and
Ricciardiello L, Carethers JM, Dowell JM, Wasserman L, ALX4 in plasma for detection of colorectal precancerous
Compton C, Mayer RJ, Bertagnolli MM, Boland CR. lesions. PLoS One 2010;5:e9061.
Characterization of sporadic colon cancer by patterns of 78. Kostin PA, Zakharzhevskaia NB, Generozov EV, Govorun VM,
genomic instability. Cancer Res 2003;63:1608-14. Chernyshov SV, Shchelygin Iu A. Hypermethylation of the
63. Goel A, Nagasaka T, Arnold CN, Inoue T, Hamilton C, CDH1, SEPT9, HLTF and ALX4 genes and their diagnostic
Niedzwiecki D, Compton C, Mayer RJ, Goldberg R, signifi cance in colorectal cancer. Vopr Onkol 2010;56:162-8.
Bertagnolli MM, Boland CR. The CpG island methylator 79. Chen WD, Han ZJ, Skoletsky J, Olson J, Sah J, Myeroff L,
phenotype and chromosomal instability are inversely correlated Platzer P, Lu S, Dawson D, Willis J, Pretlow TP, Lutterbaugh J,
in sporadic colorectal cancer. Gastroenterology 2007;132:127-38. Kasturi L, Willson JK, Rao JS, Shuber A, Markowitz SD.
64. Arnold CN, Goel A, Niedzwiecki D, Dowell JM, Detection in fecal DNA of colon cancer-specifi c methylation
Wasserman L, Compton C, Mayer RJ, Bertagnolli MM, of the nonexpressed vimentin gene. J Natl Cancer Inst
Boland CR. APC promoter hypermethylation contributes to 2005;97:1124-32.
the loss of APC expression in colorectal cancers with allelic 80. Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC 3rd,
loss on 5q. Cancer Biol Ther 2004;3:960-4. Sontag S, Johnson D, Skoletsky J, Durkee K, Markowitz S,

120 Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 3 ¦ October 15, 2015 ¦